Cargando…
Polymeric Nanoparticles for the Treatment of Malignant Gliomas
Malignant gliomas are one of the deadliest forms of brain cancer and despite advancements in treatment, patient prognosis remains poor, with an average survival of 15 months. Treatment using conventional chemotherapy does not deliver the required drug dose to the tumour site, owing to insufficient b...
Autores principales: | Mahmoud, Basant Salah, AlAmri, Ali Hamod, McConville, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017235/ https://www.ncbi.nlm.nih.gov/pubmed/31936740 http://dx.doi.org/10.3390/cancers12010175 |
Ejemplares similares
-
Development and Optimization of Irinotecan-Loaded PCL Nanoparticles and Their Cytotoxicity against Primary High-Grade Glioma Cells
por: Mahmoud, Basant Salah, et al.
Publicado: (2021) -
Box–Behnken Design of Experiments of Polycaprolactone Nanoparticles Loaded with Irinotecan Hydrochloride
por: Mahmoud, Basant Salah, et al.
Publicado: (2023) -
A Potential New Treatment for High-Grade Glioma: A Study Assessing Repurposed Drug Combinations against Patient-Derived High-Grade Glioma Cells
por: Lastakchi, Sarah, et al.
Publicado: (2022) -
Vaginal drug delivery for the localised treatment of cervical cancer
por: Major, Ian, et al.
Publicado: (2017) -
Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection
por: McConville, Christopher, et al.
Publicado: (2014)